Rodriguez et al., 1995 - Google Patents
Inducible degradation of IκBα in vitro and in vivo requires the acidic C-terminal domain of the proteinRodriguez et al., 1995
View PDF- Document ID
- 7384293991687520898
- Author
- Rodriguez M
- Michalopoulos I
- Arenzana-Seisdedos F
- Hay R
- Publication year
- Publication venue
- Molecular and cellular biology
External Links
Snippet
After exposure of cellsAfter exposure of cells to tumor necrosis factor (TNF), IκBα is rapidly degraded by a proteolytic activity that is required for nuclear localization and activation of transcription factor NF-κB. To investigate this problem, we have developed a cell-free system …
- 230000015556 catabolic process 0 title abstract description 74
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rodriguez et al. | Inducible degradation of IκBα in vitro and in vivo requires the acidic C-terminal domain of the protein | |
| Cao et al. | TRAF6 is a signal transducer for interleukin-1 | |
| Shuai et al. | A single phosphotyrosine residue of Stat91 required for gene activation by interferon-γ | |
| Tyzack et al. | ABC50 interacts with eukaryotic initiation factor 2 and associates with the ribosome in an ATP-dependent manner | |
| Mcelhinny et al. | Casein kinase II phosphorylates IκBα at S-283, S-289, S-293, and T-291 and is required for its degradation | |
| Scheper et al. | The mitogen-activated protein kinase signal-integrating kinase Mnk2 is a eukaryotic initiation factor 4E kinase with high levels of basal activity in mammalian cells | |
| Jaffray et al. | Domain organization of IκBα and sites of interaction with NF-κB p65 | |
| Cole et al. | Pheromone-induced phosphorylation of a G protein β subunit in S. cerevisiae is associated with an adaptive response to mating pheromone | |
| Hu et al. | Binding of NCK to SOS and activation of ras-dependent gene expression | |
| Law et al. | Cell cycle-regulated processing of HEF1 to multiple protein forms differentially targeted to multiple subcellular compartments | |
| Takano et al. | Four types of calpastatin isoforms with distinct amino-terminal sequences are specified by alternative first exons and differentially expressed in mouse tissues | |
| Fujita et al. | Gelsolin functions as a metasatsis suppressor in B16‐BL6 mouse melanoma cells and requirement of the carboxyl‐terminus for its effect | |
| Boldin et al. | A protein related to a proteasomal subunit binds to the intracellular domain of the p55 TNF receptor upstream to its ‘death domain’ | |
| JP2001510347A (en) | IKK-β proteins, nucleic acids and methods | |
| JP3500156B2 (en) | IκB kinases | |
| Wang et al. | Deletions and insertions within an amino-terminal domain of pp60v-src inactivate transformation and modulate membrane stability | |
| US5665859A (en) | Molecules influencing the shedding of the TNF receptor, their preparation and their use | |
| Ravid et al. | Membrane-bound Dictyostelium myosin heavy chain kinase: a developmentally regulated substrate-specific member of the protein kinase C family. | |
| Birschmann et al. | Structural and functional analysis of the interaction of the AAA‐peroxins Pex1p and Pex6p | |
| US5773237A (en) | Method for determining tyrosine kinase activity | |
| JPH10113187A (en) | Rho target protein Rho kinase | |
| JP2001510346A (en) | IKK-α proteins, nucleic acids and methods | |
| US5872206A (en) | Compositions and methods for interfering wtih hepatitis B virus infection | |
| US5654397A (en) | Interleukin-1 receptor-associated protein kinase and assays | |
| JPH11509085A (en) | Interleukin-1 receptor-related protein kinase and assay |